BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 32437415)

  • 21. Is there association between statin usage and contrast-associated acute kidney injury after intravenous administration of iodine-based contrast media in enhanced computed tomography?
    Park JH; Shin HJ; Choi JY; Lim JS; Park MS; Kim MJ; Oh HJ; Chung YE
    Eur Radiol; 2020 Oct; 30(10):5261-5271. PubMed ID: 32399711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.
    McDonald JS; McDonald RJ; Carter RE; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Apr; 271(1):65-73. PubMed ID: 24475854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions.
    Lee SR; Zhuo H; Zhang Y; Dahl N; Dardik A; Ochoa Chaar CI
    J Vasc Surg; 2020 Aug; 72(2):603-610.e1. PubMed ID: 31843298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Kidney Injury After CT in Emergency Patients with Chronic Kidney Disease: A Propensity Score-matched Analysis.
    Kene M; Arasu VA; Mahapatra AK; Huang J; Reed ME
    West J Emerg Med; 2021 Apr; 22(3):614-622. PubMed ID: 34125036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
    Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
    Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
    Briguori C; Visconti G; Ricciardelli B; Condorelli G;
    EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
    Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
    JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
    Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
    AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography.
    Filomia R; Maimone S; Caccamo G; Saitta C; Visconti L; Alibrandi A; Caloggero S; Bottari A; Franzè MS; Gambino CG; Lembo T; Oliva G; Cacciola I; Raimondo G; Squadrito G
    Medicine (Baltimore); 2016 Sep; 95(38):e4836. PubMed ID: 27661025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-contrast acute kidney injury in a hospitalized population: short-, mid-, and long-term outcome and risk factors for adverse events.
    Cheng W; Wu X; Liu Q; Wang HS; Zhang NY; Xiao YQ; Yan P; Li XW; Duan XJ; Peng JC; Feng S; Duan SB
    Eur Radiol; 2020 Jun; 30(6):3516-3527. PubMed ID: 32080754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography.
    Chua HR; Horrigan M; Mcintosh E; Bellomo R
    Biomed Res Int; 2014; 2014():506479. PubMed ID: 25180184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal trends of post-contrast acute kidney injury in patients with intravenous administration of iodinated contrast medium.
    Wu X; Yan P; Duan SB; Luo XQ; Zhang NY; Deng YH
    Ren Fail; 2023; 45(2):2251588. PubMed ID: 37724551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors and Outcomes of Postcontrast Acute Kidney Injury after Endovascular Renal Artery Intervention.
    Takahashi EA; Kallmes DF; Fleming CJ; McDonald RJ; McKusick MA; Bjarnason H; Harmsen WS; Misra S
    J Vasc Interv Radiol; 2017 Dec; 28(12):1687-1692. PubMed ID: 28947366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.
    Chaudhury P; Armanyous S; Harb SC; Ferreira Provenzano L; Ashour T; Jolly SE; Arrigain S; Konig V; Schold JD; Navaneethan SD; Nally JV; Nakhoul GN
    Nephron; 2019; 141(1):31-40. PubMed ID: 30368506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous CT Contrast Media and Acute Kidney Injury: A Multicenter Emergency Department-based Study.
    Su TH; Hsieh CH; Chan YL; Wong YC; Kuo CF; Li CH; Lee CC; Chen HY
    Radiology; 2021 Dec; 301(3):571-581. PubMed ID: 34636631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of renal function on patients with acute coronary syndromes: 15,593 patient-years study.
    Kuźma Ł; Małyszko J; Kurasz A; Niwińska MM; Zalewska-Adamiec M; Bachórzewska-Gajewska H; Dobrzycki S
    Ren Fail; 2020 Nov; 42(1):881-889. PubMed ID: 32862755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of acute kidney injury after contrast-enhanced computerized tomography: a systematic review and meta-analysis of 21 propensity score-matched cohort studies.
    Obed M; Gabriel MM; Dumann E; Vollmer Barbosa C; Weißenborn K; Schmidt BMW
    Eur Radiol; 2022 Dec; 32(12):8432-8442. PubMed ID: 35727320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
    Davenport MS; Khalatbari S; Dillman JR; Cohan RH; Caoili EM; Ellis JH
    Radiology; 2013 Apr; 267(1):94-105. PubMed ID: 23360737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.